Detalhe da pesquisa
1.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560813
2.
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Eur J Haematol
; 111(3): 485-490, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381686
3.
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
Hematol Oncol
; 35(4): 778-788, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27140599
4.
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
Eur J Haematol
; 91(3): 209-218, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23646898
5.
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Blood Adv
; 6(4): 1193-1206, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911079
6.
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.
Am J Clin Pathol
; 144(3): 484-92, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276779
7.
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Oncotarget
; 6(31): 31613-27, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26436590
8.
Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
Leuk Res
; 35(7): e128-30, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21501870